ANTABIO is a Clinical-Stage Biopharmaceutical Company with 8K followers across 2 platforms.
Last updated
ANTABIO is a clinical-stage biopharmaceutical company focused on developing novel antibacterial treatments for drug-resistant infections. Their work targets CDC and WHO critical priority pathogens, with a strong emphasis on antimicrobial resistance, carbapenem resistance, and cystic fibrosis. They actively engage with the medical and scientific community through social media and partnerships.
Developing Tomorrow’s Antibacterials.
Search interest grew +14.5% over last 10 months (regular).
Favikon helps you find the right creators, analyze them in depth, reach out at scale, and track what works.